Hitto Kaufmann - Feb 22, 2022 Form 4 Insider Report for PIERIS PHARMACEUTICALS, INC. (PIRS)

Role
SVP, Chief Scientific Officer
Signature
/s/ Megan Gates, Attorney-in-Fact
Stock symbol
PIRS
Transactions as of
Feb 22, 2022
Transactions value $
$0
Form type
4
Date filed
2/24/2022, 03:45 PM
Next filing
Feb 28, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PIRS Stock Option (Right to buy) Award $0 +216K $0.00 216K Feb 22, 2022 Common Stock 216K $3.03 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 25% of the option shares on February 22, 2023 and as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter.